title: Modulation of fatty acid-binding protein content of adult rat heart in response to chronic changes in plasma lipid levels.
abstract: The aim of this work was to study in the adult rat heart the effect of modifications of fatty acid (FA) supply on the content of cytoplasmic fatty acid-binding protein (H-FABPc). To modify the amount of circulating lipids, three different treatments were chosen: (i) an hypolipidemic treatment with Clofibrate, administered daily through a gastric tube at a dose of 250 mg/kg per day for one week, (ii) a continuous intravenous infusion of 20% Intralipid, a fat emulsion, for one week at a dose of 96 ml/kg per day, and (iii) a normobaric hypoxia exposure (pO2 = 10%) for three weeks. At the end of each treatment plasma lipids, myocardial H-FABPc content and the activities of three key enzymes (citrate synthase, CS, fructose-6-phosphate kinase, FPK and hydroxy-acyl CoA-dehydrogenase, HAD) were assessed. With each of the three treatments a decrease of plasma cholesterol and phospholipid levels was observed. Plasma FA concentration increased with Intralipid infusion and decreased with chronic hypoxia. The heart H-FABPc content was increased by 20% with Clofibrate, decreased by 20% with chronic hypoxia and remained unaltered upon Intralipid treatment. The induced changes in H-FABPc content were not related directly to changes in plasma lipid levels. CS activity was slightly decreased in the hypoxia group, FPK activity decreased in the Clofibrate group, and HAD activity decreased in the Intralipid group. Among the various groups heart H-FABPc content was related to HAD activity. In conclusion, the H-FABPc content of adult rat heart appears responsive to changes in plasma lipid levels.
authors.affiliation: Laboratoire de Physiologie Cellulaire Cardiaque, Université Joseph Fourier, Grenoble, France.
authors.forename: A
authors.initials: A
authors.lastname: Garnier
authors.forename: C
authors.initials: C
authors.lastname: Poizat
authors.forename: C
authors.initials: C
authors.lastname: Keriel
authors.forename: P
authors.initials: P
authors.lastname: Cuchet
authors.forename: M M
authors.initials: MM
authors.lastname: Vork
authors.forename: Y F
authors.initials: YF
authors.lastname: de Jong
authors.forename: J F
authors.initials: JF
authors.lastname: Glatz
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D002994:Clofibrate / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids / Q000378:metabolism*; D005260:Female; D008055:Lipids / Q000097:blood*; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D002352:Carrier Proteins; C490174:Fabp7 protein, rat; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids; D008055:Lipids; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D002994:Clofibrate; D010100:Oxygen